UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018900
Receipt number R000021874
Scientific Title Efficacy of Stress Management Program for Depressive Patients with Advanced Head and Neck Cancer: an open-label randomized controlled trial
Date of disclosure of the study information 2015/11/02
Last modified on 2023/06/29 09:12:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of Stress Management Program for Depressive Patients with Advanced Head and Neck Cancer: an open-label randomized controlled trial

Acronym

Stress Management Program for Patients with Advanced Head and Neck Cancer (SMAP-HNC study)

Scientific Title

Efficacy of Stress Management Program for Depressive Patients with Advanced Head and Neck Cancer: an open-label randomized controlled trial

Scientific Title:Acronym

Stress Management Program for Patients with Advanced Head and Neck Cancer (SMAP-HNC study)

Region

Japan


Condition

Condition

Patients with advanced head and neck cancer after initial curative treatment

Classification by specialty

Psychosomatic Internal Medicine Psychiatry Oto-rhino-laryngology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to examine the efficacy of stress management program for depressive patients with advanced head and neck cancer using an open-label randomized controlled trial.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Change in total score of Hospital Anxiety and Depression Scale (HADS) from the time of hospital discharge to the first outpatient visit

Key secondary outcomes

Change in total score of HADS from the time of hospital discharge to the 3 months after the intervention

Change in each factor's score of HADS

Change in each factor's score of Functional Assessment of Cancer Therapy - Head and Neck Cancer (FACT-H&N)

Change in each factor's score of Head and Neck Cancer Inventory (HNCI)

Change in each factor's score of Brief Coping Inventory (COPE)

Change in total score of The Athens Insomnia Scale (AIS)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Intervention:
The program, which was based a problem solving training for head and neck cancer patients and stress coping training for HIV patients, was developed by three clinical psychologists, a psychiatrist, three otorhinolaryngologists, and a nurse. We named this program as "Stress Management Program for Patients with Advanced Head and Neck Cancer (SMAP-HNC)". SMAP-HNC is conducted by clinical psychologist with a master degree. The session takes 90 minutes at the time of hospital discharge and the follow-up session takes 30 minutes at the first outpatient visit. The main purpose of the SMAP-HNC is to (1) enhance the knowledge of stress coping skill and (2) expand repertoire of stress coping skill. The themes of the sessions are: (a) psychoeducation about head and neck cancer and stress, (b) present stressor for the patients, (c) goal setting, (d) recording achievement rate of the goal, and (e) evaluation of the stress coping skill as the goal. Supportive psychotherapy is used in a variety of clinical context. All patients are treated with usual care as a controlled group.

Interventions/Control_2

Control:
All patients are treated with usual care by physicians, nurses, and other medical providers.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

(1)Who has larynx, epipharynx, oropharynx, hypopharynx, and/or oral cancer

(2)Who has a diagnosis of squamous cell cancer (SCC)

(3)Who has stage III or IV cancer

(4)Who is admitted patient after initial radiation or operation therapy

(5)Who is over 20 years old and under 80 years old

(6)Who has depression (HADS total score >=11)

Key exclusion criteria

Who cannot participate the intervention or answer the questionnaire because of his/her physical, mental, or cognitive function.

Target sample size

140


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Eisuke Matsushima

Organization

Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University

Division name

Section of Liaison Psychiatry and Palliative Medicine

Zip code


Address

1-5-45, Yushima, Bunkyo-ku, Tokyo, JAPAN

TEL

03-5803-5859

Email

em.lppm@tmd.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kanako Ichikura

Organization

Medical Hospital, Tokyo Medical and Dental University

Division name

Department of Psychosomatic and Palliative Medicine

Zip code


Address

1-5-45, Yushima, Bunkyo-ku, Tokyo, JAPAN

TEL

03-5803-5859

Homepage URL


Email

ichikura-creha@umin.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Section of Head and Neck Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University

Department of Head and Neck Surgery, Medical Hospital, Tokyo Medical and Dental University

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京医科歯科大学医学部附属病院(東京都)/Medical Hospital, Tokyo Medical and Dental University (Tokyo)


Other administrative information

Date of disclosure of the study information

2015 Year 11 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 10 Month 30 Day

Date of IRB

2015 Year 10 Month 27 Day

Anticipated trial start date

2016 Year 01 Month 25 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2020 Year 05 Month 15 Day


Other

Other related information



Management information

Registered date

2015 Year 09 Month 03 Day

Last modified on

2023 Year 06 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021874


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name